BioNano Genomics Stock News

It may seem a little crazy to talk about finding cheap penny stocks to buy at this time. The economy is cooling, and even blue-chip stocks are struggling to gain traction.

BNGO earnings call for the period ending September 30, 2022.

Bionano Genomics, Inc. (NASDAQ:BNGO ) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive Officer Christoph

Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of 8.33% and 7.78%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stoc

Select analysts and pundits foresee game-changing upside from this fast-paced trio.

Select analysts and pundits foresee game-changing upside from this fast-paced trio.

It's true that the troika of Microsoft (NASDAQ: MSFT ), Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ), and Meta (NASDAQ: META ), much loved by the Street for the decade that ended in mid-2021, reported dis

Gainers UserTesting, Inc. (NYSE: USER) shares jumped 91.7% to close at $7.40 after the company announced it will be acquired by Thoma Bravo and Sunstone Partners for $1.3 billion. The company also re

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) gained 111% to $2.03 after the company announced it entered into a license agreement with Transcosmos Digital Technology for its Apromore process mi

SAN DIEGO, Oct. 27, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO) today announced that it will host a conference call and live webcast on Thursday, November 3, 2022 at 4:30 p.m. Eastern T

Bionano's stock price movements have little to do with its successes.

Gainers View, Inc. (NASDAQ: VIEW) rose 23.2% to $1.30 in pre-market trading after declining 9% on Wednesday. Kaixin Auto Holdings (NASDAQ: KXIN) shares rose 16.5% to $0.6532 in pre-market trading aft

Bionano's stock price movements have little to do with its successes.

Bionano Genomics (NASDAQ: BNGO ) stock is rising higher on Wednesday after providing an update on its Long String VANTAGE product. This is a system that handles “automated, high throughput isolation

Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. Fangdd Netwo